Navigation Links
Sentry Enhances Offerings with Temperature-Controlled Custom Bio-Pharmaceutical Finishing Services
Date:6/17/2008

On-Demand Services Increase Flexibility While Reducing Cost and Risk

INDIANAPOLIS, June 17 /PRNewswire/ -- Sentry Logistic Solutions announced today that the company now offers temperature-controlled labeling, packaging and kitting services for the bio-pharmaceutical industry. Sentry adds controlled temperature On-Demand Services to its cGMP storage and distribution offerings. Sentry will be highlighting these new capabilities at the Bio International Convention in San Diego on June 17-20, at booth #2730.

"Custom Finishing Services are an integral part of the pharmaceutical supply chain," said Jennifer Marcum, Sentry's chief executive officer. "Sentry has the facility, expertise and quality systems to offer these valuable services On-Demand, providing our clients with flexibility in finished product delivery while reducing freight costs and storage fees. The ultimate goal of On-Demand Services is to manage risk and eliminate unnecessary supply chain costs while maintaining or exceeding service levels."

According to the Center for Drug Evaluation and Research, five of the top ten reasons for pharmaceutical recalls include miscellaneous cGMP deviations, impurities in or degradation of products, lack of product stability, labeling errors on declared strength, and incorrect products in cartons or packages. Although the exact cost of these issues is unknown, reports indicate that the pharmaceutical industry spends billions annually to rectify these issues. Because Sentry offers a cGMP, validated storage facility and inventory management system, Good Manufacturing Practices are ensured, expiration dates are managed and tracked, product integrity is maintained, and labeling or re- labeling can be accurately executed to prevent costly errors.

Sentry's On-Demand finishing services can be executed within validated temperature environments to reduce or eliminate time-out-of-temperature. Benefits of this program include decreased product risk, improved quality control, and enhanced product integrity throughout the supply chain.

Highlights and benefits of Sentry's temperature-controlled, value-added services include:

-- Labeling: Custom labeling and re-labeling support for clinical and

batch commercial applications are available. Sentry employs quality-

controlled procedures in a designated work space, total label

operation accountability (line clearance), and dose and container

flexibility.

-- Packaging: Sentry provides custom and pre-qualified packaging

(external and internal) solutions that mitigate transport impact and

agitation risk. Temperature-specific work zones reduce or eliminate

product time-out-of temperature.

-- Kitting: Offering can reduce freight and storage costs by storing bulk

products and kitting as required. Sentry can perform expiration

management of individual kit components.

About Sentry Logistic Solutions

Sentry Logistic Solutions is one of the few cGMP temperature-controlled storage and third party logistics (3PL) providers in the United States to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the warehousing, kitting, packaging, labeling and logistics needs of pharma and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.

Sentry's management team offers expertise in cold chain storage and logistics, quality assurance, pharmaceutical packaging and kitting development. Sentry also offers strategic solutions for domestic and international transportation and logistics as well as end-to-end import and export management. The company's validated processes and inventory tracking systems are FDA compliant, adhere to Good Manufacturing Practice (GMP) and comply with stringent standard operating procedures (SOP) outlined in Sentry's Validation Master Plan. Sentry is VAWD(R) accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Boards of Pharmacy(R). The company is privately held and strategically headquartered in Indianapolis, Ind. in a Foreign Trade Zone (FTZ). Sentry's FTZ service fully integrates with the company's other offerings and provides its clients with significant financial advantages and supply chain efficiencies. For more information about the company, visit Sentry at the Bio International Convention in San Diego on June 17-20 at booth #2730, visit http://www.SentryLogistic.com , or call (866) 757-7400.

MEDIA CONTACTS

Kristy Boone Amy Zucker

Synergy Marketing Group, Inc. Synergy Marketing Group, Inc.

(317) 205-9690 ext. 228 (317) 205-9690 ext. 223

kristy@synergy-mg.com amy@synergy-mg.com


'/>"/>
SOURCE Sentry Logistic Solutions
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sentry Logistic Solutions Launches Foreign Trade Zone Service
2. The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions
3. GeneNews announces management changes to support commercialization of ColonSentry(TM)
4. ScienceDirect Maximizes Research Capabilities, Enhances the Research Process
5. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
6. Visiprise Enhances Its Shop Floor Integration Solution for Manufacturers
7. Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function
8. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
9. ATS Medical Expands Open Pivot Heart Valve Offerings
10. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
11. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):